The frequency of CCR5+ CD4+ T cells was significantly higher in women with persistent BV at 6- (p = 0.0058, mean difference of 2%) and 12-weeks (p = 0.0095, mean difference of 2%) post-MDZ compared to baseline (Supplementary Figure S1). This evidence concerns the gene CD4 and bacterial vaginosis.